Menu
Search icon
  1. Home Page
    2. ›
  2. Counties
    3. ›
  3. New York
    4. ›
  4. 10036
    5. ›
  5. THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.

THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.

Company claim

Is this your business?

Get access!

Company Details

Name: THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
Jurisdiction: New York
Legal type: FOREIGN NOT-FOR-PROFIT CORPORATION
Status: Active
Date of registration: 08 Dec 2000 (25 years ago)
Entity Number: 2581999
ZIP code: 10036
County: New York
Place of Formation: Delaware
Address: ATTN: MARY E. MCDONALD, ESQ., 1133 AVENUE OF THE AMERICAS, NEW YORK, NY, United States, 10036

DOS Process Agent

Name Role Address
C/O PATTERSON BELKNAP WEBB & TYLER LLP DOS Process Agent ATTN: MARY E. MCDONALD, ESQ., 1133 AVENUE OF THE AMERICAS, NEW YORK, NY, United States, 10036

Unique Entity ID

CAGE Code:
52VM4
UEI Expiration Date:
2020-08-08

Business Information

URL:
http://www.tballiance.org
Activation Date:
2019-08-09
Initial Registration Date:
2008-05-12

Commercial and government entity program

CAGE number:
52VM4
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2025-06-16
CAGE Expiration:
2029-06-18
SAM Expiration:
2025-06-16

Contact Information

POC:
ANA MARIA HARKINS
Corporate URL:
http://www.tballiance.org

Form 5500 Series

Employer Identification Number (EIN):
134128413
Plan Year:
2019
Number Of Participants:
66
Sponsors Telephone Number:
6466168644
File:
View File
Plan Year:
2018
Number Of Participants:
63
Sponsors Telephone Number:
6466168644
File:
View File
Plan Year:
2017
Number Of Participants:
58
Sponsors Telephone Number:
6466168644
File:
View File
Plan Year:
2016
Number Of Participants:
52
Sponsors Telephone Number:
6466168644
File:
View File
Plan Year:
2015
Number Of Participants:
52
Sponsors Telephone Number:
6466168644
File:
View File

Filings

Filing Number Date Filed Type Effective Date
001208000461 2000-12-08 APPLICATION OF AUTHORITY 2000-12-08

USAspending Awards / Contracts

Procurement Instrument Identifier:
75N93024C00008
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Action Obligation:
2475623.00
Base And Exercised Options Value:
2475623.00
Base And All Options Value:
9851406.00
Awarding Agency Name:
Department of Health and Human Services
Performance Start Date:
2024-05-10
Description:
TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS.
Naics Code:
541715: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Product Or Service Code:
AN12: HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Procurement Instrument Identifier:
HHSF223201510094C
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
DCA
Action Obligation:
200000.00
Base And Exercised Options Value:
200000.00
Base And All Options Value:
200000.00
Awarding Agency Name:
Department of Health and Human Services
Performance Start Date:
2015-08-26
Description:
IGF::CL::IGF BAA CONTRACT TITLED, "CONSORTIUM FOR TB BIOMARKERS BIOREPOSITORY."
Naics Code:
541712: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
Product Or Service Code:
AZ11: R&D- OTHER RESEARCH AND DEVELOPMENT (BASIC RESEARCH)

USAspending Awards / Financial Assistance

Date:
2024-09-09
Link:
View on USAspending
Awarding Agency Name:
Department of Defense
Transaction Description:
HOST-DIRECTED APPROACHES TO TARGET GRANULOMA PATHWAYS FOR TREATMENT SHORTENING IN TUBERCULOSIS
Obligated Amount:
7352643.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2024-06-26
Link:
View on USAspending
Awarding Agency Name:
Department of Defense
Transaction Description:
HOST-DIRECTED PROTEOLYSIS-TARGETING CHIMERA (PROTAC) APPROACH TO TARGET INTRACELLULAR MYCOBACTERIUM TUBERCULOSIS (MTB). CHANGE THE START DATE. ALL OTHER TERMS AND CONDITIONS STILL APPLY.
Obligated Amount:
215429.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2021-09-17
Link:
View on USAspending
Awarding Agency Name:
Agency for International Development
Transaction Description:
THE TB ALLIANCE ACTIVITY WILL SUPPORT RESEARCH STUDIES TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL TB DRUGS AND TREATMENT REGIMENS, INCLUDING THE DEVELOPMENT AND REGULATORY AUTHORITY APPROVAL OF COMPOUNDS OR REGIMENS IN CLINICAL PHASE DEVELOPMENT. THE GOAL OF THIS ACTIVITY IS TO SUPPORT THE DISCOVERY OF BETTER, FASTER-ACTING, AND AFFORDABLE TB DRUGS.
Obligated Amount:
26000000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2020-05-03
Link:
View on USAspending
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
1433367.00
Total Face Value Of Loan:
0.00
Date:
2019-04-01
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
MODULATION OF PROTEIN PRODUCTION AND DEGRADATION AS AN INTEGRATED APPROACH TO RAPID STERILIZATION OF DRUG SENSITIVE AND RESISTANT MTB.
Obligated Amount:
28468134.09
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks Section

Serial Number:
90853289
Mark:
XTEMP-D
Status:
A fourth request for extension of time to file a Statement of Use has been granted.
Mark Type:
Trademark
Application Filing Date:
2021-07-28
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
XTEMP-D
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
pharmaceuticals dispensing device used to dissolve solid dosage forms in liquid form
International Classes:
010 - Primary Class
Class Status:
ACTIVE
Serial Number:
90853283
Mark:
XTEMP-E
Status:
A fourth request for extension of time to file a Statement of Use has been granted.
Mark Type:
Trademark
Application Filing Date:
2021-07-28
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
XTEMP-E
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
pharmaceuticals dispensing device used to dissolve solid dosage forms in liquid form
International Classes:
010 - Primary Class
Class Status:
ACTIVE
Serial Number:
90853279
Mark:
XTEMP-R
Status:
A fourth request for extension of time to file a Statement of Use has been granted.
Mark Type:
Trademark
Application Filing Date:
2021-07-28
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
XTEMP-R
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
pharmaceuticals dispensing device used to dissolve solid dosage forms in liquid form
International Classes:
010 - Primary Class
Class Status:
ACTIVE

Tax Exempt

Employer Identification Number (EIN) :
13-4128413
In Care Of Name:
% ANGELA VANDERPLOEG
Classification:
Scientific Organization
Ruling Date:
2000-09
National Taxonomy Of Exempt Entities:
Medical Research: Specifically Named Diseases Research
Deductibility:
Type of organization and use of contribution: A public charity. Deductibility Limitation: 50% (60% for cash contributions)

Reviews Leave a review

This company hasn't received any reviews.

Related by officers

C/O PATTERSON BELKNAP WEBB & TYLER LLP

79 PARSONAGE LLC AMERICAN FRIENDS OF CONTEMPORARY ART, INC. DM BRANDS, LLC MSDEWD LLC SESAME SEASON 53 PRODUCTIONS, INC. OPEN SPACE TRAILS LLC GFT APPAREL CORP. ASHLEY PHIPPS DESIGNS, LLC NEVER BETTER, LLC PB & CAVIAR LLC

Related by address

No related companies by address

Date of last update: 30 Mar 2025

Sources: New York Secretary of State

Privacy policy Policy
About us About us
Contacts Contact us

© 2025 bizyork.com, Part of Big Data Integrated